News
14h
TipRanks on MSNGlaxoSmithKline Reports Strong Q2 2025 Performance
GlaxoSmithKline ( ($GSK) ) has released its Q2 earnings. Here is a breakdown of the information GlaxoSmithKline presented to its investors.
China's Jiangsu Hengrui Pharmaceuticals said on Monday it has agreed to license the global rights of its HRS-9821 drug and 11 ...
British pharmaceutical group GlaxoSmithKline said Wednesday that its annual performance should be better than expected, ...
The Cambridge site of an international biotechnology company will cease manufacturing, leaving 150 people without a job.
Review the current GlaxoSmithKline Pharmaceuticals Ltd (GLAXO:XNSE) dividend yield and history to decide if GLAXO is the best investment for you.
A global biopharmaceutical company headquartered in London announced the layoffs of 150 Massachusetts employees last week.
U.S. Senator Maggie Hassan said on Friday she is launching an investigation into British pharmaceutical giant GlaxoSmithKline's decision to discontinue a widely used asthma inhaler for children.
GlaxoSmithKline said it would buy cancer-focused drug company Tesaro for about $4.16 billion, positioning the health-care giant in a promising, but fiercely competitive, area of medicine.
Photo by Flickr user Ian Wilson Doctors will no longer be paid to speak on behalf of GlaxoSmithKline and its products, the British drug maker said Tuesday. In addition, the pharmaceutical company ...
GlaxoSmithKline downgraded full-year earnings expectations, as its second-quarter profit was hit by currency moves, weak sales of its respiratory drugs and the continuing bribery investigation in ...
As I looked into the story at the time, several things became clear: GlaxoSmithKline was promoting the drug for use by teenagers even though it had never been cleared by the FDA for anyone under ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results